Development of PSMA-specific immunotherapy for prostate cancer with PIN4 gene-modified T cells

被引：0
|
作者：
Papa, Sophie [1 ]
Emami-Shahri, Nia [1 ]
Liu, Zhe [1 ]
Petrausch, Ulf [2 ]
Mullen, Gregory [3 ]
Spicer, James [1 ]
Maher, John [1 ]
机构：
[1] Kings Coll London, Dept Res Oncol, Div Canc Studies, London, England
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Kings Coll London, Dept Imaging Biol, Div Canc Studies, London, England
来源：
LANCET | 2014年 / 383卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [31] PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation"
    Zuccolotto, Gaia
    Penna, Alessandro
    Fracasso, Giulio
    Carpanese, Debora
    Montagner, Isabella Monia
    Dalla Santa, Silvia
    Rosato, Antonio
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] SUPPRESSION OF HUMAN PROSTATE CANCER (CAP) BY ADOPTIVE TRANSFER OF PATIENT-DERIVED PSMA-SPECIFIC, TGF-β-INSENSITIVE CD8+T CELLS
    Zhang, Qiang
    Kuzel, Timothy
    Helfand, Brian
    Yang, Ximing J.
    Qin, Weijun
    Lee, Chung
    Carneiro, Benebito
    Giles, Francis J.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1107 - E1107
  • [33] Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
    Timothy T. Spear
    Brian D. Evavold
    Brian M. Baker
    Michael I. Nishimura
    Cancer Immunology, Immunotherapy, 2019, 68 : 1881 - 1889
  • [34] Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
    Spear, Timothy T.
    Evavold, Brian D.
    Baker, Brian M.
    Nishimura, Michael I.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (11) : 1881 - 1889
  • [35] PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model.
    Smith, Jenessa Barbara
    Codde, Rebecca
    Tan, Yening
    Barnett, Barnett E.
    Hermanson, David
    Rengarajan, Srinivas
    Ostertag, Eric M.
    Shedlock, Devon J.
    CANCER RESEARCH, 2018, 78 (16) : 63 - 63
  • [36] Design of Chitosan-Coated, Quercetin-Loaded PLGA Nanoparticles for Enhanced PSMA-Specific Activity on LnCap Prostate Cancer Cells
    Essa, Divesha
    Kondiah, Pierre P. D.
    Kumar, Pradeep
    Choonara, Yahya E. E.
    BIOMEDICINES, 2023, 11 (04)
  • [37] Overcoming Resistance To Antibody Targeted Therapy in Cancer Using Gene-Modified T Cells
    Urbanska, Katarzyna
    Poussin, Mathilde
    Stashwick, Caitlin
    Smith, Jenessa B.
    Powell, Daniel J., Jr.
    MOLECULAR THERAPY, 2014, 22 : S297 - S298
  • [38] Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells
    Ohno, K
    Yoshizawa, H
    Tsukada, H
    Takeda, T
    Yamaguchi, Y
    Ichikawa, K
    Maruyama, Y
    Suzuki, Y
    Suzuki, E
    Arakawa, M
    JOURNAL OF IMMUNOLOGY, 1996, 156 (10): : 3875 - 3881
  • [39] Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer
    Tykodi, Scott S.
    Thompson, John A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (12) : 1947 - 1953
  • [40] Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
    Peinert, S.
    Prince, H. M.
    Guru, P. M.
    Kershaw, M. H.
    Smyth, M. J.
    Trapani, J. A.
    Gambell, P.
    Harrison, S.
    Scott, A. M.
    Smyth, F. E.
    Darcy, P. K.
    Tainton, K.
    Neeson, P.
    Ritchie, D. S.
    Hoenemann, D.
    GENE THERAPY, 2010, 17 (05) : 678 - 686
12345